Undisclosed novel cell therapy / Dr. Reddy’s, Edity Therapeutics - LARVOL DELTA

Edity Therapeutics Enters into a Strategic Co-Development Partnership with Aurigene Oncology to Advance a Novel Cell Therapy Program for Solid Tumors (Webwire) - "Edity Therapeutics Limited and Aurigene Oncology Limited (AOL)...announced a strategic collaboration to create novel cell therapy medicines for difficult-to-treat solid tumors....The partnership is bolstered by government grants awarded to both companies....These grants will support the initial two years of joint research efforts. Both companies will work collaboratively to co-develop first joint program for solid tumors."

Licensing / partnership • Solid Tumor